Rabies: Epidemiology, pathogenesis, and prophylaxis

被引:46
作者
Leung, Alexander K. C. [1 ]
Davies, H. Dele [2 ]
Hon, Kam-Lun Ellis [3 ]
机构
[1] Univ Calgary, Alberta Childrens Hosp, Dept Pediat, Calgary, AB, Canada
[2] Michigan State Univ, Dept Pediat & Human Dev, E Lansing, MI 48824 USA
[3] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Pediat, Shatin, Hong Kong, Peoples R China
关键词
rabies; fatal; dogs; vaccine; immune globulin;
D O I
10.1007/BF02877781
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Rabies is a viral zoonosis that causes approximately 50,000 to 100,000 deaths per year worldwide. Most deaths occur in developing countries. Dogs are the major vector, especially in developing countries. The virus is usually transmitted to humans by infected saliva through the bite of a rabid animal; the incubation period averages 30 to 90 d. Hyperexcitability, autonomic dysfunction, hydrophobia, and acrophobia are characteristic of encephalitic rabies, which accounts for 80% of cases. The paralytic form is characterized by flaccid paralysis in the bitten limb, which ascends symmetrically or asymmetrically. Once symptoms develop, the disease is invariably fatal. Animal rabies can be controlled by proper induction of herd immunity, humane removal of stray animals, promotion of responsible pet ownership through education, and enactment of leash laws. Preexposure vaccination with modern cell culture vaccine is recommended for people at high risk of exposure to rabies and for travelers who spend longer than 1 mo in countries where rabies is a constant threat, or who travel in a country where immediate access to appropriate care is limited. Postexposure prophylaxis consists of prompt and thorough wound cleansing and immunization with modern cell culture vaccine, together with administration of rabies immune globulin to those individuals who have not previously received preexposure prophylaxis.
引用
收藏
页码:1340 / 1347
页数:8
相关论文
共 32 条
  • [1] Organ transplantations and rabies transmission
    Bronnert, Jan
    Wilde, Henry
    Tepsumethanon, Veera
    Lumlertdacha, Boonlert
    Hemachudha, Thiravat
    [J]. JOURNAL OF TRAVEL MEDICINE, 2007, 14 (03) : 177 - 180
  • [2] *CATMAT, 2002, CCDR, V28, P1
  • [3] Dietzschold Bernhard, 2003, Expert Rev Vaccines, V2, P399, DOI 10.1586/14760584.2.3.399
  • [4] Safety review of the purified chick embryo cell rabies vaccine: Data from the Vaccine Adverse Event Reporting System (VAERS), 1997-2005
    Dobardzic, Azra
    Izurieta, Hector
    Woo, Emily Jane
    Iskander, John
    Shadomy, Sean
    Rupprecht, Charles
    Ball, Robert
    Braun, M. Miles
    [J]. VACCINE, 2007, 25 (21) : 4244 - 4251
  • [5] A global review of rabies vaccines for human use
    Dreesen, DW
    [J]. VACCINE, 1997, 15 : S2 - S6
  • [6] Human rabies and its prevention
    Durai, Rajaraman
    Venkatraman, Ramya
    [J]. BRITISH JOURNAL OF HOSPITAL MEDICINE, 2006, 67 (11): : 588 - +
  • [7] Intradermal rabies vaccine
    Gherardin, Anthony
    Lau, Sonny
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2007, 187 (01) : 58 - 59
  • [8] Overview, prevention, and treatment of rabies
    Hankins, DG
    Rosekrans, JA
    [J]. MAYO CLINIC PROCEEDINGS, 2004, 79 (05) : 671 - 676
  • [9] Rabies
    Hemachudha, Thiravat
    Wacharapluesadee, Supaporn
    Laothamatas, Jiraporn
    Wilde, Henry
    [J]. CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2006, 6 (06) : 460 - 468
  • [10] Current therapies in rabies
    Hendekli, CM
    [J]. ARCHIVES OF VIROLOGY, 2005, 150 (06) : 1047 - 1057